TRIP: a pathological score for transarterial chemoembolization resistance individualized prediction in hepatocellular carcinoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1478-3231|35|11|2466-2473

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.35, Iss.11, 2015-11, pp. : 2466-2473

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy of the treatment of transarterial chemoembolization combined with radiotherapy for hepatocellular carcinoma with portal vein tumor thrombus: A propensity score analysis

By  

HEPATOLOGY RESEARCH, Vol. 46, Iss. 11, 2016-10 ,pp. : 1088-1098

John Wiley & Sons Inc

Access to resources Recommend Favorite

Early Prediction of the Outcome Using Tumor Markers and mRECIST in Unresectable Hepatocellular Carcinoma Patients Who Underwent Transarterial Chemoembolization

By  

Oncology, Vol. 91, Iss. 6, 2016-10 ,pp. : 317-330

Karger

Access to resources Recommend Favorite

Superselective Transarterial Chemoembolization for Hepatocellular Carcinoma: Recent Progression and Perspective

By  

Oncology, Vol. 81, Iss. 1, 2011-12 ,pp. : 105-110

Karger

Access to resources Recommend Favorite

Efficacy of Sorafenib in Intermediate-Stage Hepatocellular Carcinoma Patients Refractory to Transarterial Chemoembolization

By  

Oncology, Vol. 87, Iss. 6, 2014-09 ,pp. : 330-341

Karger

Access to resources Recommend Favorite

Surgical resection versus transarterial chemoembolization for BCLC stage C hepatocellular carcinoma

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 111, Iss. 4, 2015-04 ,pp. : 404-409

John Wiley & Sons Inc

Access to resources Recommend Favorite